{'fraction_non_alphanumeric': 0.02722940776038121, 'fraction_numerical': 0.004765146358066712, 'mean_word_length': 5.049382716049383, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Closing the Constant Garden: The Regulation and Responsibility of U.S. Pharmaceutical Companies Doing Research on Human Subjects in Developing Nations

In Lampang, Thailand, a U.S. army doctor observed transmission rates between HIV-infected mothers and their infants without providing readily accessible medication that would likely have prevented the HIV transmission. In Buenos Aires, Argentina, a man being treated for unstable angina died after being given an experimental medication provided by a U.S.-based pharmaceutical company. It was later discovered that his signature on the treatment consent form had been forged, that he did not have unstable angina, and that the doctor who enrolled him in the study received $2,700 for doing so. Meanwhile, in Tuotuo, China, an isolated, impoverished, community where villagers live in reed huts, Harvard researchers promised free medical care to residents—but only if they were willing to donate their blood for genetic research. Subsequently, it was alleged that even though the blood was collected, in addition to millions of dollars in grant money based on the blood collection, the medical care was never provided. In Parnu, Estonia, a young man who could not resist the opportunity for a free trip to Switzerland, including travel, housing and a large stipend, agreed to test a drug that he believed was a vitamin. Once in Switzerland, he and 177 other Estonians were given consent forms that they could not read;